Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
172.35
23.68
0.00
0.00
139.71
1.52
1.52
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
172.35
23.68
0.00
0.00
139.71
1.52
1.52
Raw Material Cost
6.98
0.83
0.01
0.45
0.46
0.00
0.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
196.66
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
33.78
4.93
0.21
3.14
1.90
2.36
0.00
Selling and Distribution Expenses
179.68
120.88
66.92
33.26
25.24
21.99
15.61
Other Expenses
2.83
23.67
16.28
11.49
8.59
4.81
4.30
Total Expenditure (Excl Depreciation)
445.44
363.35
229.95
151.76
113.49
72.42
58.60
Operating Profit (PBDIT) excl Other Income
-273.09999999999997
-339.7
-230
-151.8
26.200000000000003
-70.9
-57.1
Other Income
21.45
25.84
20.80
5.37
0.60
0.62
1.49
Operating Profit (PBDIT)
-251.63
-313.82
-209.14
-145.93
27.28
-70.29
-55.60
Interest
33.78
4.93
0.21
3.14
1.90
2.36
0.00
Exceptional Items
0.00
0.00
0.00
0.19
0.00
0.00
0.00
Gross Profit (PBDT)
165.38
22.85
-0.01
-0.45
139.25
0.00
0.00
Depreciation
0.01
0.01
0.01
0.45
0.46
0.52
0.45
Profit Before Tax
-285.42
-318.76
-209.36
-149.34
24.93
-73.16
-56.05
Tax
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-285.42
-318.76
-209.36
-149.34
24.93
-77.06
-56.05
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-285.42
-318.76
-209.36
-149.34
24.93
-77.06
-56.05
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-285.42
-318.76
-209.36
-149.34
24.93
-77.06
-56.05
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
64.63
288.12
554.20
467.45
408.37
252.19
31.60
Earnings per share (EPS)
-3.29
-3.72
-2.98
-2.46
0.46
-1.87
-1.84
Diluted Earnings per share
-3.29
-3.72
-2.98
-2.46
0.46
-1.87
-1.84
Operating Profit Margin (Excl OI)
-158.45%
-1434.43%
0.0%
0.0%
18.77%
-4708.17%
-3792.95%
Gross Profit Margin
-165.6%
-1346.07%
0.0%
0.0%
18.17%
-4788.6%
-3664.86%
PAT Margin
-165.6%
-1346.11%
0.0%
0.0%
17.84%
-5080.03%
-3694.59%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 627.43% vs 0.00% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 10.48% vs -52.24% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 19.61% vs -47.76% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is 589.80% vs 2,350.00% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Syndax Pharmaceuticals, Inc. With
Figures in Million
Consolidate Annual Results
Change(USD)
Change(%)
Net Sales
172.35
46.02
126.33
274.51%
Other Operating Income
0.00
0.00
0.00
Total Operating income
172.35
46.02
126.33
274.51%
Raw Material Cost
6.98
1.23
5.75
467.48%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
196.66
92.93
103.73
111.62%
Power Cost
0
0
0.00
Manufacturing Expenses
33.78
0.00
33.78
Selling and Distribution Expenses
179.68
43.63
136.05
311.83%
Other Expenses
2.83
6.64
-3.81
-57.38%
Total Expenditure (Excl Depreciation)
445.44
204.14
241.30
118.20%
Operating Profit (PBDIT) excl Other Income
-273.08
-158.13
-114.95
-72.69%
Other Income
21.45
28.82
-7.37
-25.57%
Operating Profit (PBDIT)
-251.63
-128.09
-123.54
-96.45%
Interest
33.78
0.00
33.78
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
165.38
44.79
120.59
269.23%
Depreciation
0.01
1.23
-1.22
-99.19%
Profit Before Tax
-285.42
-129.31
-156.11
-120.73%
Tax
0.00
0.84
-0.84
-100.00%
Provisions and contingencies
0
0
0.00
Profit After Tax
-285.42
-130.15
-155.27
-119.30%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-285.42
-130.15
-155.27
-119.30%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-285.42
-130.15
-155.27
-119.30%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
64.63
614.71
-550.08
-89.49%
Earnings per share (EPS)
-3.29
-2.05
-1.24
-60.49%
Diluted Earnings per share
-3.29
-2.05
-1.24
-60.49%
Operating Profit Margin (Excl OI)
-158.45%
-343.63%
0.00
185.18%
Gross Profit Margin
-165.60%
-278.35%
0.00
112.75%
PAT Margin
-165.60%
-282.83%
0.00
117.23%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 17.24 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 627.43% vs 0.00% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit -28.54 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 10.48% vs -52.24% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) -27.31 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 19.61% vs -47.76% in Dec 2024
Annual - Interest
Interest 3.38 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 589.80% vs 2,350.00% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -158.45%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024






